CSL Behring
CSL has partnered with other pharmas to develop a potential plasma-derived therapy for treating COVID-19.
Rankings by
Национальный рейтинг193rd
in United States Региональный рейтинг210th
in North America and Caribbean Глобальный рейтинг536th
worldwide